While a global debate rages around the efficacy and safety of hydroxychloroquine (HCQ) as a preventive therapy against coronavirus, India’s apex health research body, the Indian Council of Medical Research (ICMR), has found that consuming HCQ reduces the chances of getting infected with Covid-19.
The conclusion has been drawn after three studies by the ICMR, and as result, it issued an advisory to expand the use of HCQ as a preventive therapy.
The joint monitoring group, under the chairmanship of Director General of Health Services (DGHS), and including representatives from the All India Institute of Medical Sciences (AIIMS), ICMR, National